Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells
Titel:
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells
Auteur:
Ruvolo, Peter P. Ruvolo, Vivian R. Benton, Christopher B. AlRawi, Ahmed Burks, Jared K. Schober, Wendy Rolke, James Tidmarsh, George Hail Jr, Numsen Eric Davis, R. Andreeff, Michael
Verschenen in:
Biochimica et biophysica acta. Molecular cell research